Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2007 1
2010 3
2011 4
2012 5
2013 3
2014 7
2015 3
2016 2
2017 6
2018 4
2019 6
2020 11
2021 18
2022 11
2023 13
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Evidence-based symptomatic treatment of migraine.
Mitsikostas DD, Ward TN. Mitsikostas DD, et al. Handb Clin Neurol. 2024;199:203-218. doi: 10.1016/B978-0-12-823357-3.00004-5. Handb Clin Neurol. 2024. PMID: 38307647 Review.
The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders.
Leonardi M, Martelletti P, Burstein R, Fornari A, Grazzi L, Guekht A, Lipton RB, Mitsikostas DD, Olesen J, Owolabi MO, Ruiz De la Torre E, Sacco S, Steiner TJ, Surya N, Takeshima T, Tassorelli C, Wang SJ, Wijeratne T, Yu S, Raggi A. Leonardi M, et al. J Headache Pain. 2024 Jan 4;25(1):4. doi: 10.1186/s10194-023-01700-3. J Headache Pain. 2024. PMID: 38178049 Free PMC article. Review.
Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study.
Ashina M, Mitsikostas DD, Amin FM, Kokturk P, Schankin CJ, Sahin G, Pozo-Rosich P, Dorman PJ, Nežádal T, Poole AC, Martins IP, Sumelahti ML, Ramirez Campos V, Ahn AH, Lyras L, Tassorelli C. Ashina M, et al. Among authors: mitsikostas dd. Cephalalgia. 2023 Nov;43(11):3331024231214987. doi: 10.1177/03331024231214987. Cephalalgia. 2023. PMID: 37987641 Free article. Clinical Trial.
Nocebo-associated treatment discontinuation with subcutaneous anti-osteoporotic drugs. A systematic review and meta-analysis of placebo-arm dropouts in randomized-controlled trials.
Yavropoulou MP, Kasdagli MI, Makras P, Diomatari KM, Anastasilakis AD, Mitsikostas DD, Kassi E, Sfikakis PP, Kravvariti E. Yavropoulou MP, et al. Among authors: mitsikostas dd. Maturitas. 2024 Jan;179:107874. doi: 10.1016/j.maturitas.2023.107874. Epub 2023 Oct 31. Maturitas. 2024. PMID: 37976923 Review.
Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial.
Ashina M, Lipton RB, Ailani J, Versijpt J, Sacco S, Mitsikostas DD, Christoffersen CL, Sperling B, Ettrup A. Ashina M, et al. Among authors: mitsikostas dd. Eur J Neurol. 2024 Feb;31(2):e16131. doi: 10.1111/ene.16131. Epub 2023 Nov 13. Eur J Neurol. 2024. PMID: 37955557 Clinical Trial.
Numbers needed to treat or harm and likelihood of being helped versus harmed for fremanezumab in patients who had prior inadequate response to two to four classes of migraine preventive medications: A post hoc analysis.
Ashina M, Mitsikostas DD, Ramirez Campos V, Barash S, Ning X, Diener HC. Ashina M, et al. Among authors: mitsikostas dd. Headache. 2023 Nov-Dec;63(10):1351-1358. doi: 10.1111/head.14651. Epub 2023 Nov 13. Headache. 2023. PMID: 37955395 Clinical Trial.
Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030.
Martelletti P, Leonardi M, Ashina M, Burstein R, Cho SJ, Charway-Felli A, Dodick DW, Gil-Gouveia R, Grazzi L, Lampl C, MaassenVanDenBrink A, Minen MT, Mitsikostas DD, Olesen J, Owolabi MO, Reuter U, Ruiz de la Torre E, Sacco S, Schwedt TJ, Serafini G, Surya N, Tassorelli C, Wang SJ, Wang Y, Wijeratne T, Raggi A. Martelletti P, et al. J Headache Pain. 2023 Oct 27;24(1):140. doi: 10.1186/s10194-023-01666-2. J Headache Pain. 2023. PMID: 37884869 Free PMC article. Review.
Headache Attributed to Reversible Cerebral Vasoconstriction Syndrome (RCVS).
Tentolouris-Piperas V, Lymperopoulos L, Tountopoulou A, Vassilopoulou S, Mitsikostas DD. Tentolouris-Piperas V, et al. Among authors: mitsikostas dd. Diagnostics (Basel). 2023 Aug 22;13(17):2730. doi: 10.3390/diagnostics13172730. Diagnostics (Basel). 2023. PMID: 37685270 Free PMC article. Review.
93 results